HYDROCHLOROTHIAZIDE\NEBIVOLOL: 193 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
193
Total FAERS Reports
8 (4.1%)
Deaths Reported
112
Hospitalizations
193
As Primary/Secondary Suspect
23
Life-Threatening
5
Disabilities
Active Ingredient: HYDROCHLOROTHIAZIDE\NEBIVOLOL HYDROCHLORIDE ·
First Report: 2012 · Latest Report: 20241218
What Are the Most Common HYDROCHLOROTHIAZIDE\NEBIVOLOL Side Effects?
#1 Most Reported
Acute kidney injury
46 reports (23.8%)
#2 Most Reported
Hyponatraemia
25 reports (13.0%)
#3 Most Reported
Hypokalaemia
17 reports (8.8%)
All HYDROCHLOROTHIAZIDE\NEBIVOLOL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Acute kidney injury | 46 | 23.8% | 2 | 36 |
| Hyponatraemia | 25 | 13.0% | 0 | 18 |
| Hypokalaemia | 17 | 8.8% | 0 | 12 |
| Malaise | 13 | 6.7% | 0 | 11 |
| Diarrhoea | 12 | 6.2% | 0 | 12 |
| Diabetic ketoacidosis | 11 | 5.7% | 0 | 0 |
| Cerebrovascular accident | 10 | 5.2% | 0 | 10 |
| Hyperlactacidaemia | 10 | 5.2% | 0 | 10 |
| Inappropriate antidiuretic hormone secretion | 10 | 5.2% | 0 | 10 |
| Interstitial lung disease | 9 | 4.7% | 0 | 9 |
| Antibody test abnormal | 8 | 4.2% | 0 | 8 |
| Eczema | 8 | 4.2% | 0 | 8 |
| Pemphigoid | 8 | 4.2% | 0 | 0 |
| Therapy non-responder | 8 | 4.2% | 0 | 4 |
| Dermatitis exfoliative generalised | 7 | 3.6% | 0 | 7 |
| Drug ineffective | 7 | 3.6% | 0 | 7 |
| Drug interaction | 7 | 3.6% | 0 | 7 |
| Hyperkalaemia | 7 | 3.6% | 0 | 7 |
| Hypotension | 7 | 3.6% | 0 | 4 |
| Labelled drug-drug interaction medication error | 7 | 3.6% | 0 | 7 |
Who Reports HYDROCHLOROTHIAZIDE\NEBIVOLOL Side Effects? Age & Gender Data
Gender: 45.3% female, 54.7% male. Average age: 73.2 years. Most reports from: FR. View detailed demographics →
Is HYDROCHLOROTHIAZIDE\NEBIVOLOL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 4 | 2 | 4 |
| 2014 | 11 | 0 | 10 |
| 2015 | 6 | 0 | 3 |
| 2016 | 5 | 0 | 3 |
| 2017 | 28 | 4 | 14 |
| 2018 | 34 | 0 | 17 |
| 2019 | 34 | 2 | 29 |
| 2020 | 33 | 0 | 19 |
| 2021 | 18 | 0 | 3 |
| 2022 | 4 | 0 | 2 |
| 2023 | 11 | 0 | 3 |
| 2024 | 2 | 0 | 2 |
What Is HYDROCHLOROTHIAZIDE\NEBIVOLOL Used For?
| Indication | Reports |
|---|---|
| Hypertension | 151 |
| Product used for unknown indication | 27 |
HYDROCHLOROTHIAZIDE\NEBIVOLOL vs Alternatives: Which Is Safer?
HYDROCHLOROTHIAZIDE\NEBIVOLOL vs HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL
HYDROCHLOROTHIAZIDE\NEBIVOLOL vs HYDROCHLOROTHIAZIDE\QUINAPRIL
HYDROCHLOROTHIAZIDE\NEBIVOLOL vs HYDROCHLOROTHIAZIDE\RAMIPRIL
HYDROCHLOROTHIAZIDE\NEBIVOLOL vs HYDROCHLOROTHIAZIDE\SPIRONOLACTONE
HYDROCHLOROTHIAZIDE\NEBIVOLOL vs HYDROCHLOROTHIAZIDE\TELMISARTAN
HYDROCHLOROTHIAZIDE\NEBIVOLOL vs HYDROCHLOROTHIAZIDE\TRIAMTERENE
HYDROCHLOROTHIAZIDE\NEBIVOLOL vs HYDROCHLOROTHIAZIDE\VALSARTAN
HYDROCHLOROTHIAZIDE\NEBIVOLOL vs HYDROCODONE
HYDROCHLOROTHIAZIDE\NEBIVOLOL vs HYDROCODONE/ACETAMINOPHEN
HYDROCHLOROTHIAZIDE\NEBIVOLOL vs HYDROCODONE\IBUPROFEN
Official FDA Label for HYDROCHLOROTHIAZIDE\NEBIVOLOL
Official prescribing information from the FDA-approved drug label.